HCID 54238483, compound → HCID 136401073, compound
Reaction equation
C12CCC(CC1)CN(C(C[N:13]1[C:19]3[CH:20]=[CH:21][CH:22]=[CH:23][C:18]=3[C:17]([CH2:24][CH:25]3[CH2:30][CH2:29][CH2:28][CH2:27][CH2:26]3)=[N:16][CH:15](NC(OCC3C=CC=CC=3)=O)[C:14]1=[O:42])=O)C2>CO.[OH-].[OH-].[Pd+2]>[CH:25]1([CH2:24][C:17]2[C:18]3[CH:23]=[CH:22][CH:21]=[CH:20][C:19]=3[NH:13][C:14](=[O:42])[CH2:15][N:16]=2)[CH2:26][CH2:27][CH2:28][CH2:29][CH2:30]1Participants
4
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
To a solution of (3RS)-1-[(3-azabicyclo[3.2.2]non-3-yl)carbonylmethyl]-3-benzyloxycarbonylamino-5-cyclohexylmethyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one (0.396 g) in methanol (15 ml) was added Pearlman's catalyst (0.111 g). The mixture was stirred under H2 atmosphere over night. The catalyst was filtered off by suction filtration on Celite®. The filtrate was concentrated in vacuo to give (3RS)-3-amino-1-[(3-azalicyclo[3.2.2]non-3-yl)carbonylmethyl]-5-cyclohexylmethyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one (0.298 g), which was used in a following reaction step without further purification.
Workup
- filtrationThe catalyst was filtered off by suction filtration on Celite®
- concentrationThe filtrate was concentrated in vacuo
Sources & evidence
- ORD record
- ord-5c6d949cd41e4dbfb67bf24828ebd0d1
- Source dataset
- uspto-grants-2001_09
- Patent number
- US06291452B1
Reaction notes
Loading…